Skip to main content

Bespoke Extracts, Inc. Announces Financial Results and Strategic Rebranding for the First Quarter Ended March 31, 2025

AURORA, Colo., July 01, 2025 (GLOBE NEWSWIRE) — Bespoke Extracts, Inc. (OTCQB: BSPK), a Colorado based company focused on operating in the regulated cannabis markets in the United States, today announced its financial results for the first quarter ended March 31, 2025, and highlighted the successful rebranding of its product offerings under The Joint Company.

Financial Highlights for Q1 2025:

  • Revenue Growth: Sales increased to $263,159, up 1.0% from $260,428 in Q1 2024, fueled by strong direct sales of branded pre-rolled joints and expanded joint production services for licensed dispensaries in Colorado.
  • Improved Gross Profit: Gross profit rose to $110,779 from $102,581 in Q1 2024, driven by enhanced production efficiencies in pre-rolled joints, though partially offset by higher packaging and testing costs for new product launches.
  • Reduced Operating Expenses: Operating expenses fell to $356,117 from $405,384 in Q1 2024, reflecting lower stock-based compensation, reduced salaries, and decreased professional fees.
  • Reduced Net Loss: Net loss decreased to $260,521, from $314,118 in Q1 2024.

Strategic Rebranding and Product Expansion under The Joint Company (TJC)

In Q1 2025, Bespoke Extracts successfully rebranded as The Joint Company (TJC), a pivotal step in its growth strategy. TJC scaled its white-label processing business and launched two new branded products, Doobskis and Dutch Blunts, which have gained significant traction in Colorado’s regulated cannabis market. The Fresh Joint product line continues to increase product revenue, primarily through growth in multi-packs.

Operational Highlights:

  • Through its subsidiary, Bespoke Extracts Colorado, LLC, the Company operates a marijuana-infused products manufacturing facility in Aurora, selling its products and services to licensed dispensaries in Colorado.
  • Achieved cost efficiencies in raw materials, packaging, and labor, boosting gross margins despite increased marketing and sampling costs for new product launches.
  • Daily pre-roll production increased by 32% compared to Q1 2024, enhancing TJC’s ability to offer competitive processing services and lower priced products in Colorado.
  • The Company is exploring expansion of TJC into other state-regulated cannabis markets, leveraging its successful Colorado operations experience to pursue new growth opportunities.
  • Management is focused on expanding market share and optimizing operations for sustainable, long-term growth.

Management Commentary:

Michael Feinsod, CEO of Bespoke Extracts, stated: “Q1 2025 marked a transformative period for Bespoke Extracts as we rebranded to The Joint Company and introduced Doobskis and Dutch Blunts. These initiatives, combined with enhanced third-party processing capabilities, have significantly strengthened our market position and revenue potential. Despite an 8.8% contraction in Colorado’s regulated cannabis market during the quarter ending March 31, 2025 compared to Q1 2024, we achieved year-over-year growth. Our improved manufacturing processes are delivering strong results, and we expect continued gross margin improvements as we scale. We remain committed to disciplined financial management and strategic expansion in the regulated cannabis market.”

Fiscal Q2 2025 Outlook:

  • Revenue Growth:    Based on preliminary Q2 2025 sales data, we have seen significant sales traction in our new product lines during the second quarter. The Company projects revenue exceeding $385,000 for the quarter ending June 30, 2025, compared to $278,163 in the quarter ended June 30, 2024, driven by continued growth of FreshJoints , strong demand for Doobskis and Dutch Blunts and expanded third-party processing services.
  • Operational Efficiencies: Continued improvements in manufacturing processes are expected to support higher production volumes and consistent product quality.
  • Gross Margin Improvement: Enhanced production efficiencies and cost management in raw materials, packaging, and labor are projected to drive higher gross margins, despite increased marketing investments for new product launches.
    
Balance Sheet
Condensed Consolidated Balance Sheets
(unaudited)
    
 March 31,
2025
 December 31,
2024
Assets   
Current assets   
Cash$ 30,365  $ 60,305 
Accounts receivable, net 36,757   57,276 
Prepaid Expense 17,094   15,150 
Inventory, net 38,904   32,526 
Total current assets 123,120   165,257 
    
Furniture and equipment 29,557   31,342 
License 10,000   10,000 
Right of Use Asset 73,448   140,489 
Deposits 12,000   12,000 
Total assets$ 248,125  $ 359,088 
    
Liabilities and Stockholders’ (Deficit)   
Current liabilities   
Accounts payable and accrued liabilities$ 1,123,600  $ 958,276 
Note payable 13,000   20,000 
Advances – related party 66,872   66,872 
Operating lease liability 38,063   73,523 
Total current liabilities 1,241,535   1,118,671 
    
Long-Term Liabilities   
Notes Payable – secured (net of discount ) 286,945   241,351 
Notes Payable 169,000   169,000 
Note Payable – related party 849,500   849,500 
Long-Term Operating Lease Liability 35,345   72,504 
Total liabilities 2,582,325   2,451,026 
    
Shareholders’ Deficit   
Series C Convertible Preferred Stock, 1 share issued and outstanding as of March 31,2025 and December 31, 2024     
Common stock, $0.001 par value: 3,000,000,000 authorized: 11,153,220 issued and outstanding as of March 31, 2025 and December 31, 2024 11,151   11,151 
Additional paid-in capital 24,319,286   24,301,027 
Accumulated deficit (26,664,637)  (26,404,116)
Total stockholders’ deficit (2,334,200)  (2,091,938)
Total liabilities and shareholders’ deficit 248,125   359,088 
        

Condensed Consolidated Statement of Operations
(Unaudited)
  
 For the Three Months
Ended 
March 31,
 March 31,
2025
 March 31,
024
Sales$ 263,159  $ 260,428 
Cost of products sold 152,380   157,847 
Gross Profit 110,779   102,581 
    
Operating expenses:   
Selling, general and administrative expenses 313,153   347,859 
Professional fees 42,964   57,525 
Total operating expenses 356,117   405,384 
    
Loss from Operations (245,338)  (302,803)
    
Other income/(expenses)   
Interest expense (15,183)  (11,315)
Total other (expense)/income (15,183)  (11,315)
    
Loss before income tax (260,521)  (314,118)
Provision for income tax   
Net Loss$ (260,521) $ (314,118)
    
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING   
Basic and Diluted 11,153,220   10,168,220 
    
NET LOSS PER COMMON SHARE OUTSTANDING   
Basic and Diluted$ (0.02) $ (0.03)
        
        

Forward-Looking Statements:

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including, without limitation, those set forth in the Company’s latest Form 10-K, filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.

About Bespoke Extracts, Inc.:

Bespoke Extracts, Inc. is a Nevada corporation operating in the regulated cannabis markets in the United States. Through its wholly-owned subsidiary, Bespoke Extracts Colorado, LLC, the Company operates a marijuana-infused products manufacturing facility in Aurora, Colorado, focusing on delivering high-quality products to licensed dispensaries under its rebranded portfolio, The Joint Company.

Contact:

Bespoke Extracts, Inc.
Email: info@bespokeextracts.com
Website: www.bespokeextracts.com

Note: The financial data in this press release is derived from the Company’s unaudited consolidated financial statements included in its Form 10-Q for the quarter ended March 31, 2025, filed with the SEC. Forward-looking revenue projections and expansion plans are based on management’s current expectations and are subject to change.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.